Skip to Main Content

Paper Details

Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes.
Ann Hematol
42
2022
Author NameAffiliation
Daniel J DeAngeloDana-Farber Cancer Institute
Martin S TallmanMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2